Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A2JK4Q / Name: Polyphor / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction

Polyphor AG Stock

Pros and Cons of Polyphor AG in the next few years

Pros
?
B****
?
M***** P*******
?
C******** o* t** e**********
Cons
?
S********** s********
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee.
Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee.
Spexis expects that audit of its 2023 financials will not be completed by 31 July 2024, provides status update relating to the Company’s moratorium and changes to its Executive Committee.
Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc.
Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc.
Spexis AG: PARI Pharma GmbH announces termination of ColiFin® license to EnBiotix, Inc.
Spexis launches appeal against SIX Exchange Regulation decision to suspend trading of its shares.
Spexis launches appeal against SIX Exchange Regulation decision to suspend trading of its shares.
Spexis launches appeal against SIX Exchange Regulation decision to suspend trading of its shares.